Current guidelines recommend its use in all patients with T1DM, T2DM, or any other forms of diabetes (e.g., gestational diabetes) on multiple subcutaneous insulin injections (MSII). Self-monitoring of blood glucose (SMBG) is an invaluable method of monitoring glycemic status. Apart from type-2 diabetes mellitus (T2DM), which constitutes a bulk of this disease burden, India has also witnessed an exponential increase in the burden of T1DM, and globally it has the second largest population of children and young adults with T1DM, second only to the USA. India is the diabetes capital of the world, with diabetes and prediabetes prevalence of 9% and 11%–14%, respectively. Children with fabrication consistently had the highest HbA1c values among the different types of inaccurate blood glucose chartings, which was statistically significant at 32 and 36 months of follow-up. In the remaining 7, it was the child himself/herself. Among logs with fabrication, parents were responsible in 2 of 9 incidents. Of the 14 children who had omissions, 9 had omission of high values only, 3 patients had omission of low values only, 1 had omission of both high and low values, and 1 had omission of normal values. The same was reflected in the proportion of children achieving HbA1c <7% and 7%–9%. During follow-up of 44 months, children with accurate SMBG logs consistently had lower HbA1c as compared to children having inaccurate logs, which was statistically significant at 4, 16, 20, and 28 months' follow-up. Age was not significantly different among children having accurate versus inaccurate SMBG logs. The most common observed error was omission (42.42%), followed by fabrication (27.27%), erroneous (18.18%), and others (12.12%).
Errors in glucose charting were observed in 32.67% children.